Angiodynamics Inc
Nasdaq: ANGO
- 22 clinical trials, 10 active
- FDA-cleared or approved devices
Life science companies
Explore 34,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
MDI Therapeutics, Inc.
- Raised $1.7 million (2022)
- 2 clinical trials
- Research grants: $7.3 million
- Founded 2022
Fate Therapeutics Inc
Nasdaq: FATE
- Raised $50 million (2020)
- 25 clinical trials, 6 active
- Founded 2007
Paratek Pharmaceuticals, Inc.
- Raised $93 million (2014)
- 14 clinical trials, 1 active
- Research grants: $3.8 million
Adma Biologics, Inc.
Nasdaq: ADMA
- Private funding (2013)
- 7 clinical trials
- 1 FDA-registered drug site
Neogen Corp
Nasdaq: NEOG
- FDA-cleared or approved devices
- 1 FDA-registered drug site
- Research grants: $38,554
Arrowhead Pharmaceuticals, Inc.
Nasdaq: ARWR
- Raised $64 million (2013)
- 51 clinical trials, 14 active
INSMED Inc
Nasdaq: INSM
- Raised $84 million (2010)
- 49 clinical trials, 7 active
Elysium Therapeutics, Inc.
- Raised $2.2 million (2022)
- 1 clinical trial
- Research grants: $10 million
- Founded 2013
Flugen Inc
- Raised $8.2 million (2020)
- 6 clinical trials
- Research grants: $9.8 million
- Founded 2007
Adient Medical, Inc.
- Raised $14 million (2022)
- 1 clinical trial, 1 active
- Research grants: $8.4 million
- Founded 2012
ArriVent BioPharma, Inc.
Nasdaq: AVBP
- Raised $110 million (2022)
- 6 clinical trials, 6 active
- Founded 2021
Basking Biosciences, Inc.
- Raised $55 million (2025)
- 3 clinical trials, 1 active
- Research grants: $4.5 million
- Founded 2019
CASI Pharmaceuticals, Inc.
OTC: CASIF
- Raised $5 million (2026)
- 23 clinical trials, 2 active
- Founded 2023
Celcuity Inc.
Nasdaq: CELC
- Raised $130 million (2025)
- 5 clinical trials, 3 active
- Founded 2011
Cerenome, Inc.
Nasdaq: CNSY
- Raised $300,000 (2020)
- 5 clinical trials, 5 active
- Research grants: $249,877
Clarametyx Biosciences, Inc.
- Raised $28 million (2024)
- 2 clinical trials
- Research grants: $6.3 million
- Founded 2020
CONMED Corp
NYSE: CNMD
- 2 clinical trials, 2 active
- FDA-cleared or approved devices
Contraline, Inc.
- Raised $56 million (2026)
- 1 clinical trial
- Research grants: $3.6 million
- Founded 2017
Janux Therapeutics, Inc.
Nasdaq: JANX
- Raised $125 million (2021)
- 5 clinical trials, 5 active
- Founded 2017
Showing 500 of 34,266 companies
Load morePublished company profiles only; counts update daily. Data licences